Search
Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.
Integrative medicine specialists determine which complementary therapies appear to be most effective.
In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.
Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.
In this Q&A we discuss MSK’s pioneering work in rectal MRI, how it differs from endorectal ultrasound (ERUS), its role in groundbreaking clinical trials for patients with rectal cancer, why expertise matters, and new frontiers for future improvements to rectal MRI.
A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.
People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth in this cohort.
As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.